Italy - Sold Production of Antisera and Vaccines
Since 2014, Italy Sold Production of Antisera and Vaccines grew 2.8% year on year. At €494,355,529.09 in 2019, the country was number 7 comparing other countries in Sold Production of Antisera and Vaccines. Italy is overtaken by Sweden, which was ranked number 6 with €697,925,096.51 and is followed by Belgium with €105,497,423.06. Ireland lead the ranking with €14,786,673,398.66 in 2019, -11.1% compared to 2018. France, Germany and United Kingdom respectively ranked number 2, 3 and 4 in this ranking. Ireland witnessed the best average annual growth at +45.5% per year, while Austria recorded the worst performance at -100% per year.
Loading...
| Date | Euros |
|---|---|
| 2019 | 494,355,529.09 |
| 2018 | 362,881,000.00 |
| 2017 | 874,524,000.00 |
| 2016 | 419,451,000.00 |
| 2015 | 410,937,000.00 |
Download all data from 1995 to 2019
How does Italy rank in Sold Production of Antisera and Vaccines?
| # | 17 Countries | Euros | Last | YoY | 5‑years CAGR | ||
|---|---|---|---|---|---|---|---|
| 1 |
#1
Ireland
|
14,786,673,398.66 | 2019 | -11.1 % | +45.5 % | View data | |
| 2 |
#2
France
|
3,996,634,665.74 | 2019 | +1.4 % | +25.2 % | View data | |
| 6 |
#6
Sweden
|
697,925,096.51 | 2019 | +3.1 % | +13.7 % | View data | |
| 7 |
#7
Italy
|
494,355,529.09 | 2019 | +36.2 % | +2.8 % | View data | |
| 8 |
#8
Belgium
|
105,497,423.06 | 2019 | -14.8 % | -11.9 % | View data | |